TM
RMD icon

Torren Management’s ResMed RMD Stock Holding History

Torren Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988 Hold
5
– – ﹤0.01% 732
2026
Q1 		$1.14K Sell
5
-254
-98% -$63.3K ﹤0.01% 709
2025
Q4 		$62.4K Buy
+259
New +$66.2K 0.03% 259

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Torren Management's RMD Position: Q2 2026 in Review

Torren Management held its ResMed (RMD) position steady in Q2 2026 at 5 shares worth $988. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Torren Management first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $62.4K in Q4 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Torren Management held 5 shares of ResMed worth $988 as of Q2 2026.
  • Torren Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #732 holding.
  • Torren Management first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's ResMed position peaked at $62.4K in Q4 2025.
  • 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.